Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
Tuesday, April 30th 2024, 3:07:16 pm
article
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit
Breaking
Hopes rise for a US-Iran nuclear deal as Islamabad mediates talks, with key disputes over uranium enrichment and stockpiles nearing a solution....
Major international bodies have rejected a ‘parallel government’ in Sudan, warning it could deepen divisions and derail peace efforts amid ongoing war...
Interim BBC Director General Rhodri Talfan Davies has told employees that as many as 2,000 jobs will be axed to curb expenses...
